PODCAST

Vital Compliance Insights

Deanna

Healthcare regulatory compliance resource

government

All Episodes

11:10

How A Federal Shutdown Weakens Nursing Home Oversight...

Vital Compliance Insights ·

2025/11/10

We examine how the federal shutdown disrupts nursing home oversight, why CMS triaged surveys to emergencies, and the risks created by fewer inspectors and furloughed staff. We share steps facilities can take to protect residents, drawing lessons from the OIG’s pandemic report. • status of the shutdown and date context • CMS priorities for complaint investigations and revisits • suspension of recertification and initial surveys • state surveyor staffing gaps and missed annua...

en-us

20:55

Why Active Medical Director Engagement Protects...

Vital Compliance Insights ·

2025/10/20

We examine how CMS F841 and new OIG oversight raise expectations for nursing home medical directors, demanding visible engagement, better policies, and data-informed leadership. We share field lessons on antipsychotics, facility assessment, and building dashboards that support real accountability. • CMS shifts from F501 to F841 and clarifies medical director duties • OIG focus on engagement, visit frequency, and compensation integrity • Risks of absent or passive medical directors in daily c...

en-us

10:30

Congress Hits Brakes on Nursing Home Staffing Rules...

Vital Compliance Insights ·

2025/09/17

en-us

25:56

Navigating MDS Accuracy in Long-Term Care

Vital Compliance Insights ·

2025/09/03

Accurate MDS completion has become a regulatory lightning rod as the OIG and CMS intensify their scrutiny of long-term care documentation. This shift isn't merely procedural—it signals a comprehensive effort to identify potential fraud and ensure residents receive appropriate care based on accurate assessments. The recent OIG work plan specifically targets resident falls resulting in major injuries, with investigators cross-referencing hospital claims against facility MDS documentation. When...

en-us

20:40

Understanding the Resident is the First Step to...

Vital Compliance Insights ·

2025/08/04

en-us

14:11

OIG - Compliance Committee, Risk Assessment &...

Vital Compliance Insights ·

2025/07/28

OIG 2023-2024 Compliance Guidance for Long Term Care Facilities is summarized to highlight importance of a compliance committee and the responsibility to assist the chief compliance officer to develop a robust facility risk assessment. From that assessment the committee would need to develop meaningful and accessible policies and procedures to guide all levels of the facility staff and consultants of their roles and responsibilities in maintaining healthcare compliance.

en-us

14:03

OIG Compliance Guidance Overview 2023-2024 for Long...

Vital Compliance Insights ·

2025/06/13

In this podcast episode, the host discusses the 2023 and 2024 updates to OIG's compliance program guidance (CPGs). These updates include a move to publishing the CPGs on the OIG website and the addition of a section on quality and patient safety. The host emphasizes the importance of incorporating quality and patient safety into compliance programs and discusses their personal experiences as a health care analyst working with corporate integrity agreements. The episode concludes with a quote ...

en-us

15:03

OIG focus on Chief Compliance Officer Role

Vital Compliance Insights ·

2025/06/13

In this episode, I will discuss the OIG November 2023 Compliance Officer Roles and Responsibilities guidance. The compliance officer has a responsibility to develop policies and procedures, conduct risk assessments, provide education and training, and promptly investigate any reports of abuse or fraud. They must also foster a culture of open communication and transparency within the organization and have open access to the board to report concerns and updates on the compliance program.

en-us

35:09

CMS Revisions to Psychotropic Medication Use

Vital Compliance Insights ·

2025/05/08

Skilled nursing facilities are facing changes in CMS survey guidance regarding unnecessary use of psychotropic medications. CMS is closely monitoring the use of these medications, which can be considered chemical restraints, and is asking facilities to focus on behavior interventions to minimize use. CMS is emphasizing the importance of professional standards of practice and the role of the medical director in monitoring the use of these medications. The use of psychotropic medications,...

en-us

21:32

CMS 2025 Long Term Care Regulatory Overview

Vital Compliance Insights ·

2025/04/22

Summary The CMS has released updated guidance on the long-term care survey process, focusing on accuracy of the MDS, medical director responsibilities, psychotropic medications and chemical restraints. In addition, the CMS issued clarifications for enhanced barrier precautions, pain management, quality assurance and performance improvement, health care equity, and prohibits certain language in admission agreements. It is important to recognize that healthcare surveyors will be looking f...

en-us

0:55

OIG test

Vital Compliance Insights ·

2025/04/02

Testing music upload

en-us

11 results

Vital Compliance Insights

All Episodes

Similar Podcasts

The Fly

Georgetown"s Institute of Politics and...

THE CONSTITUTION STUDY

Paul Engel

The DSR Daily

The DSR Network

The Lawfare Podcast

The Lawfare Institute

Fora do Baralho

Rádio Observador